Treatment of type 2 diabetes: The sooner, the better [1]

Journal of Internal Medicine

Volumn 250, Issue 3, 2001, Pages 255-257

  Yamada, T ^a   Komatsu, M ^b   Sato, A ^c   Komiya, I ^d   Yamauchi, K ^b   Aizawa, T ^b   Hashizume, K ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

CLINICAL TRIAL; DISEASE DURATION; EXERCISE; FAMILY HISTORY; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LETTER; NEPHROTIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UREMIA; VASCULAR DISEASE;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0035723268     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00873.x     Document Type: Letter

References (8)

1. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
2. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment
3. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man
4. Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus
5. Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: An overview
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
7. The war against diabetes. How will we know if we are winning?